| 1. |
Abad CL, Lahr BD, Razonable RR. Epidemiology and risk factors for infection after living donor liver transplantation. Liver Transpl, 2017, 23(4): 465-477.
|
| 2. |
鄭樹森, 俞軍, 張武. 肝移植在中國的發展現狀. 臨床肝膽病雜志, 2014, 30(1): 2-4.
|
| 3. |
中國肝移植注冊. https://www.cltr.org.
|
| 4. |
Singh N, Gayowski T, Wagener M, et al. Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. Transplantation, 1994, 58(7): 774-778.
|
| 5. |
Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis, 1995, 21(5): 1077-1089.
|
| 6. |
Kawecki D, Chmura A, Pacholczyk M, et al. Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit, 2009, 15(12): C628-C637.
|
| 7. |
Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant, 2005, 5(1): 125-130.
|
| 8. |
周英鳳, 鐘婕, 李麗, 等. 構建證據生態系統, 推動循證護理實踐發展. 護士進修雜志, 2019, 34(3): 193-197.
|
| 9. |
朱政, 胡雁, 邢唯杰, 等. 不同類型循證問題的構成. 護士進修雜志, 2017, 32(21): 1991-1994.
|
| 10. |
Dicenso A, Bayley L, Haynes RB. Accessing pre-appraised evidence: fine-tuning the 5S model into a 6S model. Evid Based Nurs, 2009, 12(4): 99-101.
|
| 11. |
Murad MH, Montori VM, Ioannidis JP, et al. How to read a systematic review and meta-analysis and apply the results to patient care: users’ guides to the medical literature. JAMA, 2014, 312(2): 171-179.
|
| 12. |
The Joanna Briggs Institute (JBI). (2017-07-15) [2017-11-24]. http://joannabriggs.org/research/critical-appraisal-tools.html.
|
| 13. |
Chávez-Tapia NC, González-Rodrígueza L, Jeong M, et al. Current evidence on the use of probiotics in liver diseases. J Funct Foods, 2015, 17: 137-151.
|
| 14. |
魏曉晨, 朱立勤, 王春革. 聯用益生菌和益菌生對肝移植患者術后細菌感染影響的系統評價. 中國新藥雜志, 2013, 22(23): 2779-2785.
|
| 15. |
王有軍, 張翠萍. 益生菌對肝移植術后患者感染的影響及相關因素 Meta 分析. 中國微生態學雜志, 2017, 29(11): 1261-1264.
|
| 16. |
Eguchi S, Takatsuki M, Hidaka M, et al. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg, 2011, 201(4): 498-502.
|
| 17. |
Zhang Y, Chen J, Wu J, et al. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg Nutr, 2013, 2(3): 142-147.
|
| 18. |
劉海潮, 張水軍, 郭文治. 益生菌應用于肝移植術后患者的臨床意義. 中國普通外科雜志, 2013, 22(1): 71-74.
|
| 19. |
Motanya J. Evaluation of the safety of probiotic use in transplant recipients. Jane Gervasio (Butler University), 2014.
|
| 20. |
The Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party. Supporting Document for the Joanna Briggs Institute levels of Evidence and Grades of Recommendation. The Joanna Briggs Institute. 2014. http://joannabriggs.org/jbi-approach.html#tabbed-nav-Levels-of-Evidence.
|